久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • SK's Skyzoster grabs Korean market share from Merck's Zostavax fiercepharma
    March 15, 2018
    As Merck’s shingles shot Zostavax is challenged by GlaxoSmithKline’s Shingrix in the U.S., it's also quickly yielding market share in South Korea to SK Chemicals’ Skyzoster—and Merck is blaming that on SK’s pricing and marketing tactics.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service